Critical Developmental Periods for Effects on Male Rat Genitalia Induced by Finasteride, a 5α-Reductase Inhibitor

    March 1993 in “ Toxicology and Applied Pharmacology ”
    R. M. Clark, Craig S. Anderson, S. Prahalada, R. G. H. Robertson, Elizabeth A. Lochry, Y.M. Leonard, Jamie Stevens, Alan M. Hoberman
    Image of study
    TLDR Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.
    The study investigated the effects of finasteride, a 5α-reductase inhibitor, on male rat genitalia during critical developmental periods. The critical period for inducing the effects of finasteride on male rat development, including hypospadias with cleft prepuce, decreased anogenital distance, presence of nipples, and decreased prostate weight, is during gestational days 16 to 17. Finasteride prevented the formation of the medial mesenchymal plate, which is responsible for separating the urethral plate from the ventral surface of the genital tubercle to form the penile urethra. The study concludes that finasteride could also likely cause hypospadias in male human fetuses considering the known effects of congenital 5α-reductase deficiency in humans.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Six months of only Dermarolling

      in Progress Pictures  157 upvotes 1 year ago
      User tried dermarolling for hair loss and shared progress pictures. Some suggest adding finasteride and minoxidil, while others debate effectiveness and frequency of dermarolling.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 2 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community NW5 at 19. How many grafts do I need?

      in Transplants  140 upvotes 1 year ago
      A 19-year-old with rapid hair loss since 16 is considering a hair transplant but refuses to take finasteride or any 5α-Reductase inhibitors. They are currently using minoxidil, tretinoin, and microneedling with a Derminator 2, and only want hair until age 27.

    Related Research

    3 / 3 results